Bariatric Surgery CandidateSADINCT04165694
Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision
A study testing Single Anastomosis Duodenal Ileal Bypass (SADI) in people with Bariatric Surgery Candidate and Severe Obesity, run by Kaiser Permanente at 1 site in United States.
Trial summary
The goal of this study is two part: 1) to add to the literature which is still somewhat sparse with numbers of patients undergoing the Single Anastomosis Duodenal Ileal Bypass (SADI) as a revision for laparoscopic sleeve gastrectomy (LSG) and 2) to have a treatment option for our Kaiser Permanente patients who seek… Read more about this study
- Who is it for?
- Ages 18 to 100 yearsHealthy volunteers can take part
- Conditions the study is for
- Bariatric Surgery Candidate, Severe Obesity
- What is being tested?
- Single Anastomosis Duodenal Ileal Bypass (SADI)
- Type of treatment
- Surgery or procedure
- How many people
- 54 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Oct 2019to 1 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Body Mass Index (BMI) 35 - 39 kg/m2 with comorbid conditions; OR
- BMI 40+ kg/m2 with no comorbidities; AND
- having a previous laparoscopic sleeve gastrectomy (LGS); AND
- having lost less than 10% total weight loss with this LSG; AND
- being a Kaiser member at the time of surgery; AND
- being at least 18 years of age.
Who cannot join
- BMI less than 35 kg/m2; OR
- having a hiatal hernia; OR
- having severe Gastroesophageal Reflux Disease; OR
- having a primary bariatric procedure other than LSG; OR
- having already had a revisional bariatric procedure; OR
- being less than 18 years old.
Trial locations and contacts
1 site in 1 country.
United States1 site
Kaiser Permanente Southern California West Los Angeles Medical Center
Los Angeles, California, 90034
About this study
Official title: Single Anastomosis Duodenal Ileal Bypass (SADI) as a Second Stage for Sleeve Gastrectomy Weight Loss Failure
The goal of this study is two part: 1) to add to the literature which is still somewhat sparse with numbers of patients undergoing the Single Anastomosis Duodenal Ileal Bypass (SADI) as a revision for laparoscopic sleeve gastrectomy (LSG) and 2) to have a treatment option for our Kaiser Permanente patients who seek additional assistance after a LSG with persistent morbid obesity and the comorbidities that come with it.
Read the detailed description
Patients will be recruited during 10/15/2019 through 04/30/2022 with the following inclusion criteria: 1) body mass index (BMI) 35 - 39 kg/m2 with comorbid conditions; 2) BMI 40+ kg/m2 with no comorbidities; 3) having a previous LGS; 4) having lost less than 10% total weight loss with this LSG; 5) being a Kaiser member at the time of surgery; and 6) being at least 18 years of age. Exclusion criteria will include: 1) BMI less than 35; 2) having a hiatal hernia; 3) having severe Gastroesophageal Reflux Disease; 4) having a primary bariatric procedure other than LSG; 5) having already had a revisional bariatric procedure; and 6) being less than 18 years old.
Age range for participants will be 18 - 100 years old. We will recruit 50 patients.
Revisional procedures for weight regain are PART OF USUAL CARE at Kaiser Permanente Southern California. However SADI is a type of revisional procedure that is still considered experimental. This procedure has a single surgical anastomosis. It has a restrictive component when reducing the greater curvature of the stomach, but specially a malabsorptive component, as the common channel is also reduced. The objective of this surgical technique is to lessen the intestinal loop where nutrients are absorbed. It was part of a more extreme procedure, that is currently standard of care, called the Duodenal Switch (DS).
The DS procedure which is PART OF USUAL CARE results in very successful massive weight loss however, it also has severe complications especially vitamin deficiencies. The SADI procedure is thought to confer the same weight loss benefits of the DS but without the severe complications. This has not been tested systematically.
These eligibility criteria will be verified by the bariatric surgeon who is doing the consult for a revisional procedure AS PART OF USUAL CARE. This will entail the surgeon looking in the electronic medical record before meeting with the patient. However, this review of the medical record before surgical consult is PART OF USUAL CARE.
All data collection and study follow-up visits are PART OF USUAL CARE for bariatric patients at Kaiser Permanente Southern California. THIS INCLUDES PATIENTS WHO RECEIVE REVISIONAL SURGERY. The only part of the study that is not usual care is the surgical procedure itself. The patients enrolled in the proposed study will receive the following visits AS PART OF USUAL CARE:
- Surgical consult 2 - 6 weeks before surgery at which point the patients will be offered the SADI procedure and consent will be done by the surgeon doing the consult in person in the surgeon's office in the Department of Surgery at the West Los Angeles Medical Center.
- Visit with bariatric physician 7 - 10 days before surgery to go over laboratory values and to insure instructions for surgical preparation were followed.
- Visit with surgeon and bariatric physician 7 - 10 days after surgery.
- Visit with bariatric physician 4 - 6 weeks after surgery.
- Visit 6 months after surgery with surgeon, bariatric physician, and other te am members as necessary (i.e. nutritionist or social worker).
- Visit 12 months after surgery with surgeon, bariatric physician, and other team members as necessary (i.e. nutritionist or social worker).
- Annual phone calls at years 1, 2 and 3 after surgery with bariatric care manager to monitor laboratory measures, weight loss, and complications.
All data to evaluate the effectiveness of SADI will be abstracted from the electronic medical record. These measures are taken from the patients as PART OF USUAL CARE. There are no specific measures added to usual care for the SADI procedure. We already have a protocol for the DS procedure. These data will include weight, height, laboratory results, diagnoses, utilization of services, and pharmacy records. No questionnaires will be used in this study.
For each patient, data will be abstracted for 12 months before surgery and up to 3 years after surgery. No questionnaires will be administered.
The primary outcome for the study will be percent total weight loss at 3 years calculated as (weight at surgery - weight at 3 years)/weight at surgery. Data will be analyzed using linear regression to predict what factors at baseline such as disease burden, gender, age, race ethnicity, and BMI predict percent total weight loss at 3 years.
- Conditions
- Bariatric Surgery Candidate, Severe Obesity
- Being tested
- Single Anastomosis Duodenal Ileal Bypass (SADI)
- Keywords
- weight loss failure, laparoscopic sleeve gastrectomy
- Medical subject headings
- Obesity, Morbid
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Single Anastomosis Duodenal Ileal Bypass (SADI)Procedure or surgery
The purpose of the research is to study additional weight loss and resolution of comorbidities in patients who undergo revision of their sleeve gastrectomy to a Single Anastomosis Duodenal Ileal bypass (SADI). The sleeve gastrectomy which you have already undergone is now the most common bariatric procedure performed. This operation was part of a 2-stage operation known a Duodenal Switch (DS) which was a sleeve gastrectomy followed by a long bypass of the intestine that involved 2 connections. This operation has many complications such as vitamin deficiencies and potential malnutrition. The SADI procedure is a version of the DS that bypasses less of the intestine and one less connection of the small bowel.
What is being measured
The primary outcome is the main question the study is designed to answer.
Percent Total Weight Loss (change in weight relative to baseline)
This is weight loss relative to the initial body weight at the time of surgery calculated as (weight at surgery - weight at follow-up)/weight at surgery. This is already a change score.
Measured: 3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Nov 2019
- Study start15 Oct 2019
- Primary completion1 May 2025
- Study completion1 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bariatric Surgery CandidateStudies of the same condition, open and under way.
- More trials run by Kaiser PermanenteThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- The study is a pre-/post-test prospective intervention.
- Masking
- None (open label)
- Enrolment
- 54 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kaiser Permanente
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04165694
- Sponsor's protocol ID
- 12208
- Acronym
- SADI
- Status last verified
- Aug 2026
- First submitted
- 7 Nov 2019
- Last updated
- 6 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Single Anastomosis Duodenal Ileal Bypass (SADI) as a Second Stage for Sleeve Gastrectomy Weight Loss Failure
- ClinicalTrials.gov ID
- NCT04165694
- Acronym / sponsor ID
- SADI / 12208
- Conditions
- Bariatric Surgery Candidate, Severe Obesity
- Keywords
- weight loss failure, laparoscopic sleeve gastrectomy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 54 participants (actual)
- Lead sponsor
- Kaiser PermanenteUniversity, hospital or other
- Study start
- 15 Oct 2019 (actual)
- Primary completion
- 1 May 2025 (actual)
- Study completion
- 1 May 2025 (actual)
- First posted
- 18 Nov 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is two part: 1) to add to the literature which is still somewhat sparse with numbers of patients undergoing the Single Anastomosis Duodenal Ileal Bypass (SADI) as a revision for laparoscopic sleeve gastrectomy (LSG) and 2) to have a treatment option for our Kaiser Permanente patients who seek additional assistance after a LSG with persistent morbid obesity and the comorbidities that come with it.
Detailed description
Patients will be recruited during 10/15/2019 through 04/30/2022 with the following inclusion criteria: 1) body mass index (BMI) 35 - 39 kg/m2 with comorbid conditions; 2) BMI 40+ kg/m2 with no comorbidities; 3) having a previous LGS; 4) having lost less than 10% total weight loss with this LSG; 5) being a Kaiser member at the time of surgery; and 6) being at least 18 years of age. Exclusion criteria will include: 1) BMI less than 35; 2) having a hiatal hernia; 3) having severe Gastroesophageal Reflux Disease; 4) having a primary bariatric procedure other than LSG; 5) having already had a revisional bariatric procedure; and 6) being less than 18 years old.
Age range for participants will be 18 - 100 years old. We will recruit 50 patients.
Revisional procedures for weight regain are PART OF USUAL CARE at Kaiser Permanente Southern California. However SADI is a type of revisional procedure that is still considered experimental. This procedure has a single surgical anastomosis. It has a restrictive component when reducing the greater curvature of the stomach, but specially a malabsorptive component, as the common channel is also reduced. The objective of this surgical technique is to lessen the intestinal loop where nutrients are absorbed. It was part of a more extreme procedure, that is currently standard of care, called the Duodenal Switch (DS).
The DS procedure which is PART OF USUAL CARE results in very successful massive weight loss however, it also has severe complications especially vitamin deficiencies. The SADI procedure is thought to confer the same weight loss benefits of the DS but without the severe complications. This has not been tested systematically.
These eligibility criteria will be verified by the bariatric surgeon who is doing the consult for a revisional procedure AS PART OF USUAL CARE. This will entail the surgeon looking in the electronic medical record before meeting with the patient. However, this review of the medical record before surgical consult is PART OF USUAL CARE.
All data collection and study follow-up visits are PART OF USUAL CARE for bariatric patients at Kaiser Permanente Southern California. THIS INCLUDES PATIENTS WHO RECEIVE REVISIONAL SURGERY. The only part of the study that is not usual care is the surgical procedure itself. The patients enrolled in the proposed study will receive the following visits AS PART OF USUAL CARE:
- Surgical consult 2 - 6 weeks before surgery at which point the patients will be offered the SADI procedure and consent will be done by the surgeon doing the consult in person in the surgeon's office in the Department of Surgery at the West Los Angeles Medical Center.
- Visit with bariatric physician 7 - 10 days before surgery to go over laboratory values and to insure instructions for surgical preparation were followed.
- Visit with surgeon and bariatric physician 7 - 10 days after surgery.
- Visit with bariatric physician 4 - 6 weeks after surgery.
- Visit 6 months after surgery with surgeon, bariatric physician, and other te am members as necessary (i.e. nutritionist or social worker).
- Visit 12 months after surgery with surgeon, bariatric physician, and other team members as necessary (i.e. nutritionist or social worker).
- Annual phone calls at years 1, 2 and 3 after surgery with bariatric care manager to monitor laboratory measures, weight loss, and complications.
All data to evaluate the effectiveness of SADI will be abstracted from the electronic medical record. These measures are taken from the patients as PART OF USUAL CARE. There are no specific measures added to usual care for the SADI procedure. We already have a protocol for the DS procedure. These data will include weight, height, laboratory results, diagnoses, utilization of services, and pharmacy records. No questionnaires will be used in this study.
For each patient, data will be abstracted for 12 months before surgery and up to 3 years after surgery. No questionnaires will be administered.
The primary outcome for the study will be percent total weight loss at 3 years calculated as (weight at surgery - weight at 3 years)/weight at surgery. Data will be analyzed using linear regression to predict what factors at baseline such as disease burden, gender, age, race ethnicity, and BMI predict percent total weight loss at 3 years.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Model description
- The study is a pre-/post-test prospective intervention.
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Body Mass Index (BMI) 35 - 39 kg/m2 with comorbid conditions; OR
- BMI 40+ kg/m2 with no comorbidities; AND
- having a previous laparoscopic sleeve gastrectomy (LGS); AND
- having lost less than 10% total weight loss with this LSG; AND
- being a Kaiser member at the time of surgery; AND
Key exclusion criteria (6 listed)
- BMI less than 35 kg/m2; OR
- having a hiatal hernia; OR
- having severe Gastroesophageal Reflux Disease; OR
- having a primary bariatric procedure other than LSG; OR
- having already had a revisional bariatric procedure; OR
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Single Anastomosis Duodenal Ileal Bypass (SADI)The purpose of the research is to study additional weight loss and resolution of comorbidities in patients who undergo revision of their sleeve gastrectomy to a Single Anastomosis Duodenal Ileal bypass (SADI). The sleeve gastrectomy which you have already undergone is now the most common bariatric procedure performed. This operation was part of a 2-stage operation known a Duodenal Switch (DS) which was a sleeve gastrectomy followed by a long bypass of the intestine that involved 2 connections. This operation has many complications such as vitamin deficiencies and potential malnutrition. The SADI procedure is a version of the DS that bypasses less of the intestine and one less connection of the small bowel. | Procedure or surgery | – |
Primary outcome
Percent Total Weight Loss (change in weight relative to baseline)
Time frame: 3 years
This is weight loss relative to the initial body weight at the time of surgery calculated as (weight at surgery - weight at follow-up)/weight at surgery. This is already a change score.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Bariatric Surgery Candidate
Active, not recruiting
Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial
Bariatric Surgery Candidate, Obesity
Active, not recruiting
Stepwise PEEP vs Sustained Inflation in Bariatric Surgery Patients
Recruitment, Bariatric Surgery Candidate
RecruitingObservational study
Blood Collection Biorepository for Liver Disease Research
Non-Alcoholic Steatohepatitis(NASH), Hepatitis C
Enrolling by invitationObservational study
Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome
Obese, Healthy
Active, not recruiting
Evaluation of the Stress Response in Bariatric Surgery With and Without the Use of Opioids
Opioid Use, Unspecified, Bariatric Surgery Candidate
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Single Anastomosis Duodenal Ileal Bypass (SADI) in people with Bariatric Surgery Candidate and Severe Obesity, run by Kaiser Permanente at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percent Total Weight Loss (change in weight relative to baseline) (time frame: 3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.